iifl-logo

Jubilant Pharmova Ltd Profit & Loss Statement

879.5
(-1.67%)
Mar 25, 2025|02:44:52 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

2,709.49

3,139.9

3,306.32

2,491.22

yoy growth (%)

-13.7

-5.03

32.71

-6.2

Raw materials

-1,450.36

-1,684.42

-1,780.39

-1,307.02

As % of sales

53.52

53.64

53.84

52.46

Employee costs

-220.67

-264.9

-264.41

-226.3

As % of sales

8.14

8.43

7.99

9.08

Other costs

-611.4

-819.66

-722.26

-639.87

As % of sales (Other Cost)

22.56

26.1

21.84

25.68

Operating profit

427.05

370.9

539.24

318

OPM

15.76

11.81

16.3

12.76

Depreciation

-99.97

-107.39

-82.59

-81.12

Interest expense

-101.8

-136.19

-135.17

-174.25

Other income

47.88

173.23

46.21

51.89

Profit before tax

273.16

300.54

367.69

114.52

Taxes

-58.69

22.3

-104.25

-35.32

Tax rate

-21.48

7.42

-28.35

-30.84

Minorities and other

0

0

0

0

Adj. profit

214.47

322.84

263.44

79.19

Exceptional items

0

-1.7

0

0

Net profit

214.47

321.14

263.44

79.19

yoy growth (%)

-33.21

21.9

232.65

8.48

NPM

7.91

10.22

7.96

3.17

Jubilant Pharmo : related Articles

Jubilant Pharmova Passes FDA Audit, Expands R&D with Pierre Fabre
26 Sep 2024|07:42 PM

This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.

Read More
FDA Issues VAI Status to Jubilant HollisterStier's Washington Facility
11 Sep 2024|11:23 AM

Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.

Read More
Top 10 stocks for today – 11th September, 2024
11 Sep 2024|09:23 AM

Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.

Read More
Jubilant Pharmova arm to pick up 80% stake in Pierre Fabre’s centre
19 Aug 2024|01:36 PM

Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.